Publication:
Oxidative Post-translational Protein Modifications upon Ischemia/Reperfusion Injury.

dc.contributor.authorBinek, Aleksandra
dc.contributor.authorCastans, Celia
dc.contributor.authorJorge, Inmaculada
dc.contributor.authorBagwan, Navratan
dc.contributor.authorRodriguez, Jose Manuel
dc.contributor.authorFernandez-Jimenez, Rodrigo
dc.contributor.authorGalan-Arriola, Carlos
dc.contributor.authorOliver, Eduardo
dc.contributor.authorGomez, Monica
dc.contributor.authorClemente-Moragón, Agustín
dc.contributor.authorIbáñez, Borja
dc.contributor.authorCamafeita, Emilio
dc.contributor.authorVazquez, Jesus
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderFundación ProCNICes_ES
dc.contributor.funderComunidad de Madrid (España)es_ES
dc.contributor.funderFundación La Caixaes_ES
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderUnión Europea. Comisión Europea. 7 Programa Marcoes_ES
dc.contributor.funderMinisterio de Educación, Cultura y Deporte (España)es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)es_ES
dc.date.accessioned2024-03-21T16:39:48Z
dc.date.available2024-03-21T16:39:48Z
dc.date.issued2024-01-16
dc.description.abstractWhile reperfusion, or restoration of coronary blood flow in acute myocardial infarction, is a requisite for myocardial salvage, it can paradoxically induce a specific damage known as ischemia/reperfusion (I/R) injury. Our understanding of the precise pathophysiological molecular alterations leading to I/R remains limited. In this study, we conducted a comprehensive and unbiased time-course analysis of post-translational modifications (PTMs) in the post-reperfused myocardium of two different animal models (pig and mouse) and evaluated the effect of two different cardioprotective therapies (ischemic preconditioning and neutrophil depletion). In pigs, a first wave of irreversible oxidative damage was observed at the earliest reperfusion time (20 min), impacting proteins essential for cardiac contraction. A second wave, characterized by irreversible oxidation on different residues and reversible Cys oxidation, occurred at late stages (6-12 h), affecting mitochondrial, sarcomere, and inflammation-related proteins. Ischemic preconditioning mitigated the I/R damage caused by the late oxidative wave. In the mouse model, the two-phase pattern of oxidative damage was replicated, and neutrophil depletion mitigated the late wave of I/R-related damage by preventing both Cys reversible oxidation and irreversible oxidation. Altogether, these data identify protein PTMs occurring late after reperfusion as an actionable therapeutic target to reduce the impact of I/R injury.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study was supported by competitive grants from the MCIN/AEI/10.13039/501100011033/ and FEDER Una manera de hacer Europa (PID2021-122348NB-I00 and PID2022-140176OB-I00), the MCIN/AEI/10.13039/501100011033 the Unión Europea NextGenerationEU/PRTR (PLEC2022- 009235, and PLEC2022-009298), the Comunidad de Madrid (Programa S2022/BDM-7333-CM, INMUNOVAR, P2022/BMD-7333, and RENIM-CM, P2022/BMD-7403), “la Caixa” Banking Foundation (HR17- 00247, LCF/PR/HP22/52320018, and LCF/PR/HR22/52420019), and the European Commission (ERC Consolidator Grant “MATRIX”, 819775). Rodrigo Fernandez-Jimenez is the recipient of grant PI22/01560 funded by the ISCIII-Fondo de Investigación Sanitaria and co-funded by the European Union. Aleksandra Binek and Navratan Bagwan were FP7-PEOPLE-2013-ITN-Cardionext fellows from the European Union’s Seventh Framework Programme (Marie Curie Actions). Celia Castans holds a Formación del Profesorado Universitario (FPU14/05292) fellowship from the Spanish Ministry of Education, Culture and Sports. Eduardo Oliver holds a Ramón y Cajal fellowship (RYC2020-028884- I) and granted by the MCIN/AEI/10.13039/501100011033/ and FEDER Una manera de hacer Europa (PID2021-133167OB-100) and by “ESF Investing in your future”. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN), and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIN/AEI/10.13039/501100011033).es_ES
dc.format.number1es_ES
dc.format.volume13es_ES
dc.identifier.citationAntioxidants (Basel). 2024 Jan 16;13(1):106.es_ES
dc.identifier.doi10.3390/antiox13010106es_ES
dc.identifier.issn2076-3921es_ES
dc.identifier.journalAntioxidants (Basel, Switzerland)es_ES
dc.identifier.pubmedID38247530es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19038
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021-122348NB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2022-140176OB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PLEC2022-009235es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PLEC2022-009298es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/S2022/BDM-7333-CMes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/P2022/BMD-7333es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/P2022/BMD-7403es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/HR17-00247es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/LCF/PR/HP22/52320018es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/LCF/PR/HR22/52420019es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FPU14/05292es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RYC2020-028884-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021-133167OB-100es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MICIN/AEI/10.13039/501100011033/CEX2020-001041-Ses_ES
dc.relation.publisherversion10.3390/antiox13010106es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Proteómica cardiovasculares_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleOxidative Post-translational Protein Modifications upon Ischemia/Reperfusion Injury.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication1ade9fd4-6ff0-41d9-8edb-9746d704b6ee
relation.isAuthorOfPublicationbe8e4232-4d07-4ac1-b969-ee3344c5b7c3
relation.isAuthorOfPublication692b9503-3e2f-4789-8903-521fdd0115f3
relation.isAuthorOfPublication968d7ae4-b328-44e3-a561-d6505e5345b4
relation.isAuthorOfPublication63e55d34-c1c9-439c-bc46-f5b9830e538a
relation.isAuthorOfPublicationa6bead57-638c-4bc1-96de-94d972aa3e2c
relation.isAuthorOfPublication7a3eb52c-08fc-474a-8bca-e069339a4bc6
relation.isAuthorOfPublication6ac0323c-934c-4156-8099-cbf453615d48
relation.isAuthorOfPublication01fe2999-8e1e-4911-af9d-ea1f3172b31d
relation.isAuthorOfPublication2cac8bb6-2bff-4bf6-8209-bdbd21781786
relation.isAuthorOfPublication620c7d10-2b0e-45a4-a556-9f84b9d6df64
relation.isAuthorOfPublication9743763b-919c-4fa9-a53c-57c41be5e0ac
relation.isAuthorOfPublication.latestForDiscovery1ade9fd4-6ff0-41d9-8edb-9746d704b6ee

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Oxidative Post-translational_Antioxidants_ 2024.pdf
Size:
5.98 MB
Format:
Adobe Portable Document Format
Description:
Artículo